Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma
Clinical trial NCT05617430 · UNKNOWN
Trial details
- NCT number
- NCT05617430
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-02
- Primary completion
- 2024-04-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.